Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

SMMT

Summit Therapeutics (SMMT)

Summit Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SMMT
DateTimeSourceHeadlineSymbolCompany
02/09/20227:00AMGlobeNewswire Inc.Summit Therapeutics Announces Postponement of Its Planned Rights OfferingNASDAQ:SMMTSummit Therapeutics Inc
01/25/20224:16PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SMMTSummit Therapeutics Inc
01/25/20226:30AMGlobeNewswire Inc.Summit Therapeutics Announces Rights OfferingNASDAQ:SMMTSummit Therapeutics Inc
01/12/20223:09PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SMMTSummit Therapeutics Inc
01/10/20227:00AMGlobeNewswire Inc.Summit Therapeutics Today Presents Its Company Vision at 40th Annual J.P. Morgan Healthcare Virtual ConferenceNASDAQ:SMMTSummit Therapeutics Inc
01/05/20223:09PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SMMTSummit Therapeutics Inc
01/05/20223:04PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SMMTSummit Therapeutics Inc
01/05/20223:02PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SMMTSummit Therapeutics Inc
01/05/20226:30AMGlobeNewswire Inc.Summit Therapeutics to Present Company Vision at 40th Annual J.P. Morgan Healthcare Virtual ConferenceNASDAQ:SMMTSummit Therapeutics Inc
12/21/20215:16AMTipRanksH.C. Wainwright Remains a Hold on Summit Therapeutics (SMMT)NASDAQ:SMMTSummit Therapeutics Inc
12/20/20213:24PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SMMTSummit Therapeutics Inc
12/20/20217:30AMGlobeNewswire Inc.Summit Therapeutics Announces Topline Results for Phase III Ri-CoDIFy Study for C. Difficile InfectionNASDAQ:SMMTSummit Therapeutics Inc
12/17/20213:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SMMTSummit Therapeutics Inc
11/15/20213:54PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SMMTSummit Therapeutics Inc
11/15/20217:47AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SMMTSummit Therapeutics Inc
11/15/20217:40AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SMMTSummit Therapeutics Inc
11/15/20217:30AMGlobeNewswire Inc.Summit Therapeutics Inc Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended September 30, 2021NASDAQ:SMMTSummit Therapeutics Inc
11/03/20217:30AMGlobeNewswire Inc.Summit Therapeutics Bolsters Its Board of Directors with Seasoned Regulatory & Clinical Research Executive Dr. Urte GaykoNASDAQ:SMMTSummit Therapeutics Inc
10/12/20217:41AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SMMTSummit Therapeutics Inc
10/08/20217:30AMGlobeNewswire Inc.Summit Therapeutics Appoints Prominent Biotech Attorney and Advisor Kenneth A. Clark to Its Board of DirectorsNASDAQ:SMMTSummit Therapeutics Inc
09/30/20218:00AMGlobeNewswire Inc.Summit Therapeutics Presents Further Breakthrough Insights Surrounding the Novel Mechanism of Action for its Investigational Drug Ridinilazole During IDWeek 2021NASDAQ:SMMTSummit Therapeutics Inc
09/30/20217:00AMPR Newswire (US)Antimicrobials Working Group Highlights Member Company Participation at IDWeek 2021NASDAQ:SMMTSummit Therapeutics Inc
09/21/20213:06PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SMMTSummit Therapeutics Inc
08/12/20213:19PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SMMTSummit Therapeutics Inc
08/11/20217:39AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SMMTSummit Therapeutics Inc
08/11/20217:01AMGlobeNewswire Inc.Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter and Six Months Ended June 30, 2021NASDAQ:SMMTSummit Therapeutics Inc
08/11/20217:00AMGlobeNewswire Inc.Summit Therapeutics Provides Update on Ri-CoDIFy TrialsNASDAQ:SMMTSummit Therapeutics Inc
08/05/20217:00AMPR Newswire (US)Acurx Pharmaceuticals Joins the Antimicrobials Working GroupNASDAQ:SMMTSummit Therapeutics Inc
07/12/20217:29AMGlobeNewswire Inc.Summit Therapeutics Presents Breakthrough Research Data from Phase II Studies, including Evidence Validating Microbiome Prese...NASDAQ:SMMTSummit Therapeutics Inc
07/09/20213:40PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SMMTSummit Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:SMMT

Your Recent History

Delayed Upgrade Clock